
Clearlake to buy majority stake in ModMed that values it at $5.3bn
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Private equity group Clearlake Capital is close to clinching a deal to buy a majority stake in healthcare software company Modernizing Medicine in a buyout that values the group at $5.3bn including debt, according to…